ZOLTAN LABORATORIES, LLC
for
the Development of Placental Alkaline Phosphatase
for Cancer Cachexia and Bone Marrow Protection

Provide recombinant Placental Alkaline Phosphatase (PLAP) for cancer patients to prevent muscle wasting and body weight loss (cachexia) as well as therapy induced deterioration of bone marrow function.

In contrast to the prevailing view, our science strongly supports the view that to avoid or lessen cancer cachexia and maintain bone marrow health, treatment of patients with PLAP must start right after tumor detection along with the primary cancer treatment.